Pr. Pentel et al., REVERSAL OF DESIPRAMINE TOXICITY IN RATS WITH POLYCLONAL DRUG-SPECIFIC ANTIBODY FAB FRAGMENTS, The Journal of laboratory and clinical medicine, 123(3), 1994, pp. 387-393
Citations number
22
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Drug-specific antibodies, or fragments containing their binding site(s
), are a potential means of treating drug overdose. Affinity purified
polyclonal ovine Fab (TFab) with a high average affinity constant (K-a
= 1.4 x 10(10) M(-1)) for the common tricyclic antidepressants was ev
aluated as a possible treatment for tricyclic antidepressant toxicity.
Groups of eight anesthetized rats received 30 mg/kg body weight of de
sipramine (DMI) intraperitoneally, followed after 15 minutes by a In-m
inute intravenous injection of 3 ml normal saline solution, 2 gm/kg no
nspecific Fab as a control (CFab), or 1 or 2 gm/kg TFab (representing
a molar ratio of TFab to DMI of 0.11 and 0.22, respectively). The anim
als were observed for 3 hours. During the initial 15 minutes, serum DM
I levels in the four groups reached 2.3 to 2.9 mu g/ml, the QRS durati
on increased by 67.5% to 77.9%, and the systolic pressure fell to betw
een 65% and 85% of its initial value. The group given saline solution
showed a gradual return of all these parameters toward normal, whereas
CFab caused a transient further QRS prolongation. CFab also caused an
initial rise in blood pressure, which then fell progressively, and tw
o of the rats died 2 to 3 hours later with hypotension and bradycardia
. Serum DMI concentration did not change significantly in either the s
aline or CFab groups. Conversely, the groups given 1 gm/kg or 2 gm/kg
of TFab showed an immediate 13-fold and 17-fold rise in their serum DM
I concentrations, a prompt and marked fall in the QRS duration when co
mpared with the saline and CFab groups (p < 0.01) that was sustained t
hroughout the study period, and improved blood pressure. However, one
of the rats receiving the larger dose of TFab died. These findings dem
onstrate that TFab rapidly reduces DMI cardiotoxicity and support the
potential value of this therapeutic approach. The cause of the three d
eaths is uncertain but may relate to the rapid rate of infusion of rel
atively large amounts of Fab.